Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 6, 2025 /PRNewswire/ -- Faruqi & Faruqi, ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Red Cat To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $75,000 in Red Cat between March 18, 2022 and January 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 4, 2025 /PRNewswire/ ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $100,000 in Iovance between May 9, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 4, 2025 /PRNewswire/ -- Far ...

Core Viewpoint - A securities class action lawsuit has been filed against Organon & Co. for allegedly misrepresenting its capital allocation priorities and significantly reducing its quarterly dividend [1][6]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the District of New Jersey [1]. - Investors who acquired Organon shares during the class period (October 31, 2024 – April 30, 2025) are encouraged to contact the law firm before the lead plaintiff motion deadline on July 22, 2025 [1][3][6]. Group 2: Allegations Against Organon - Organon is accused of concealing material information regarding its capital allocation priorities, particularly about its quarterly dividend [6]. - The company allegedly misrepresented its commitment to dividends while internally prioritizing debt reduction [6]. - Following the acquisition of Dermavant Sciences Ltd., Organon reduced its quarterly dividend by over 70% [6].

Core Viewpoint - A securities class action lawsuit has been filed against Krispy Kreme, alleging false or misleading statements regarding its partnership with McDonald's and the subsequent decline in product demand [1][6]. Allegations - Krispy Kreme allegedly made false or misleading statements and/or failed to disclose a significant decline in demand for products at McDonald's after the initial marketing launch [6]. - This decline led to lower average sales per location [6]. - The partnership with McDonald's was reportedly not profitable [6]. - These issues posed risks to the continuation of the partnership [6]. - As a result, Krispy Kreme would pause expanding to new McDonald's locations [6]. Legal Context - The law firm Wolf Haldenstein, with over 125 years of experience in securities litigation, is representing the investors affected by these alleged misrepresentations [4]. - Investors who purchased Krispy Kreme securities during the specified class period have until July 15, 2025, to request to be appointed as Lead Plaintiff [2].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Canopy Growth Corporation due to allegations of misleading statements and undisclosed costs that negatively impacted the company's financial performance [2][4]. Group 1: Allegations and Financial Impact - The complaint alleges that Canopy Growth and its executives violated federal securities laws by making false statements and failing to disclose significant costs related to the Claybourne product launch and Storz & Bickel vaporizer devices [4]. - Canopy reported a gross margin decrease of 400 basis points to 32% in Q3 2025, primarily due to costs associated with the Claybourne infused pre-roll launch and increased indirect costs related to vaporizer devices [5]. - The company experienced a wider-than-anticipated loss of C$1.11 per share in Q3 2025, compared to the C$0.48 per share loss estimated by analysts [5]. Group 2: Market Reaction - Following the announcement of the financial results, Canopy's share price fell by $0.76, or 27.34%, closing at $2.02 per share on February 7, 2025 [7]. Group 3: Legal Proceedings - Investors who purchased Canopy securities between May 30, 2024, and February 6, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and the June 3, 2025, deadline to seek lead plaintiff status in the class action [2][8].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against DoubleVerify Holdings, Inc. due to allegations of misleading statements and failure to disclose critical information affecting investors [2][4]. Group 1: Allegations Against DoubleVerify - The complaint alleges that DoubleVerify's customers are shifting ad spending from open exchanges to closed platforms, where the company's technological capabilities are limited [4]. - It is claimed that DoubleVerify's ability to monetize its high-margin Activation Services is constrained due to the high costs and time required for technology development for closed platforms [4]. - The complaint states that DoubleVerify's competitors are better positioned to incorporate AI into their offerings, negatively impacting DoubleVerify's competitive edge and profitability [4]. - Allegations include that DoubleVerify systematically overbilled customers for ad impressions served to declared bots, and that risk disclosures were materially false and misleading [4]. Group 2: Impact of Disclosures - The truth about the alleged fraud was revealed through disclosures in February and March 2025, leading to a significant stock price drop of 36% following disappointing earnings [5]. - A report from Adalytics Research in March 2025 claimed that DoubleVerify's services were ineffective, further damaging investor confidence [5]. Group 3: Legal Proceedings - Investors who suffered losses in DoubleVerify are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options for participating in a federal securities class action [1][2]. - The deadline for seeking the role of lead plaintiff in the class action is set for July 21, 2025 [2].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ibotta, Inc. due to allegations of misleading statements and failure to disclose risks related to its contract with Kroger, which may have led to significant investor losses [2][4]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Ibotta to contact them to discuss legal options, particularly in light of a federal securities class action filed against the company [1][2]. - The deadline for investors to seek the role of lead plaintiff in the class action is June 16, 2025 [2]. Group 2: Financial Performance and Stock Impact - Ibotta conducted its IPO on April 13, 2024, offering 6.6 million shares at $88.00 each [5]. - The company reported a net loss of $34.0 million for Q2 2024, with operating expenses more than doubling year-over-year, leading to a 26% drop in stock price to $42.66 on August 14, 2024 [6]. - On February 26, 2025, Ibotta's stock fell 46% to $34.01 after reporting Q4 earnings that missed expectations and provided disappointing guidance for Q1 2025 [7]. Group 3: Contractual Risks - The complaint against Ibotta alleges that the company did not disclose the at-will nature of its contract with Kroger, which allowed Kroger to terminate the agreement without notice, posing a significant risk to investors [4].

Core Viewpoint - A securities class action lawsuit has been filed against Krispy Kreme, alleging false or misleading statements regarding its partnership with McDonald's and the subsequent decline in product demand [1][7]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals or entities who purchased Krispy Kreme securities between February 25, 2025, and May 7, 2025 [1]. - Investors have until July 15, 2025, to request to be appointed as Lead Plaintiff for the class [2]. Group 2: Allegations Against Krispy Kreme - Krispy Kreme allegedly failed to disclose a significant decline in demand for its products at McDonald's following the initial marketing launch [7]. - This decline resulted in lower average sales per location and indicated that the partnership with McDonald's was not profitable [7]. - The issues raised in the lawsuit suggest risks to the continuation of the partnership, leading Krispy Kreme to pause its expansion to new McDonald's locations [7]. Group 3: Legal Representation - Wolf Haldenstein Adler Freeman & Herz LLP, a law firm with over 125 years of experience in securities litigation, is representing the investors [4]. - The firm emphasizes its commitment to seeking justice for investors who have suffered financial harm due to misrepresented statements [4].

ATLANTA, May 27, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) complied with federal securities laws. On May 27, 2025, Savara announced that it had received a refusal to file letter from the FDA for the Biologics License Application of MOLBREEVI as a therapy to treat patients with autoimmune pulmonary alveolar proteinosis. Following this news, the price of the Company’s stock dropped.  If you purchased Savara stock and suffered  ...